Invention Application
- Patent Title: HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
- Patent Title (中): 异构体化合物及其使用方法
-
Application No.: US13347541Application Date: 2012-01-10
-
Publication No.: US20120178748A1Publication Date: 2012-07-12
- Inventor: John Emmerson CAMPBELL , Philip JONES , Michael Charles HEWITT
- Applicant: John Emmerson CAMPBELL , Philip JONES , Michael Charles HEWITT
- Applicant Address: US MA Marlborough
- Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee Address: US MA Marlborough
- Main IPC: A61K31/5383
- IPC: A61K31/5383 ; A61K31/519 ; A61K31/437 ; C07D498/14 ; C07D487/04 ; C07D471/04 ; C07D491/147 ; A61P3/04 ; C07D471/14 ; A61P25/00 ; A61P3/00 ; A61P25/18 ; A61P25/28 ; A61P25/22 ; A61P25/24 ; A61P25/16 ; A61P25/20 ; A61P3/10 ; A61K31/4985

Abstract:
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
Public/Granted literature
- US08765760B2 [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases Public/Granted day:2014-07-01
Information query
IPC分类: